SHAREHOLDER NOTICE: Rosen Law Firm Reminds CTI BioPharma

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER NOTICE: Rosen Law Firm Reminds CTI BioPharma Corp. Investors of Important April 11, 2016 Deadline in Class Action – CTIC

NEW YORK, April 08, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of CTI BioPharma Corp. securities (NASDAQ: CTIC ) pursuant to and/or traceable to the Registration Statement and Prospectus issued in connection with CTI BioPharma’s September 24, 2015 Public Offering (the “offering”) and/or from March 4, 2014 through February 9, 2016, inclusive (the “Class Period”) of the important April 11, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for CTI BioPharma investors under the federal securities laws.

To join the CTI BioPharma class action, go to the firm’s website at http://rosenlegal.com/cases-837.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, the documents filed in connection with the offering contained materially false and misleading statements and omissions, including: (1) the detrimental effect on survival of pacritinib; (2) CTI BioPharma’s clinical trials demonstrated deaths associated with pacritinib usage; (3) CTI BioPharma’s new drug application for pacritinib would likely be withdrawn; (4) as such, CTI BioPharma’s future revenues were impaired; (5) CTI BioPharma lacked adequate internal controls; and (6) as a result, CTI BioPharma’s financial statements and Defendants’ statements about CTI BioPharma’s business, operations, and prospects, were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-837.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT: Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY  10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com kchan@rosenlegal.com www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 394

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 278

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 181

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 194

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 137

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 201

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 202

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Notice: Humacyte Investors Should Act Now

Updated Category News Views 117

Understanding the Investigation into Humacyte Faruqi & Faruqi, LLP, a prominent national law firm specializing in securities litigation, is actively looking into potential claims related to Humacyte, Inc. (NASDAQ: HUMA). This investigation comes as a significant opportunity for investors who may have suffered losses exceeding $75,000 during certain periods of the...

Continue Reading
Marco's Pizza Partners with Karate Kid: Legends for Film Launch

Updated Category News Views 206

Marco's Pizza and Karate Kid: Legends Collaboration In an exciting move to engage fans, Marco's Pizza, one of the fastest-growing pizza franchises, has teamed up with Sony Pictures' Karate Kid: Legends. This collaboration aims to celebrate the cherished Karate Kid series with a mouthwatering promotion that promises to delight both pizza and movie enthusiasts. Delicious...

Continue Reading
Innovative Tactile Makeup Palette Supports Vision Impaired Users

Updated Category News Views 352

Introduction to an Inclusive Beauty Initiative Makeup has long been synonymous with beauty and self-expression, yet it has often excluded a significant segment of the population: those who are blind or have low vision. Recognizing this critical gap, the Shine Foundation has collaborated with Cheekbone Beauty to create a groundbreaking solution in the beauty...

Continue Reading
Carver Bancorp Appoints Donald Felix as New Leader

Updated Category News Views 196

Carver Bancorp Welcomes Donald Felix as President and CEO Carver Bancorp, Inc. has made a significant announcement: Donald Felix is now its President and CEO. This marks an important chapter for Carver, which is well-known for its dedication to supporting underserved communities. A Legacy of Service and Community Investment Established in 1948, Carver has consistently led...

Continue Reading
Navigating Merger Concerns with SpartanNash Company Insights

Updated Category News Views 258

Understanding the SpartanNash Merger Situation As the merger of SpartanNash Company (NASDAQ: SPTN) with C&S Wholesale Grocers unfolds, there’s considerable interest in the deal, which proposes a cash buyout of $26.90 per share for SpartanNash shareholders. This sort of transaction can be complex, and it prompts many to wonder whether the offer truly represents a fair...

Continue Reading